Klaus Engel, CEO, Evonik Industries
ESSEN, GERMANY: The investment is Evonik’s largest single chemical investment to date for €500 million. The company plans to strengthen its amino acids business with the construction of an all new 150,000 tonne per year methionine complex in Singapore. The completely backward-integrated plant on Jurong Island will not only produce the amino acid methionine, which is in high demand for animal feed, but also all the strategically important raw materials required for the production process.
Commercial operations are scheduled to begin in the second half of 2014. The new facility will boost the company’s total annual capacity for this amino acid to 580,000 metric tonne by 2014, an increase of more than 60 per cent in just five years.
“Methionine is one of our core businesses, which we are now strengthening considerably in the Asian growth market by making this major investment. This also should bring us closer to our customers in Asia and makes us a solid, reliable, long-term partner,” said Klaus Engel, CEO, Evonik Industries.
By taking this step in Singapore, the company will enjoy a presence in all world regions, as is achievable with modern and highly efficient production facilities. Evonik consistently expanded the existing facilities in North America and Europe over the years to meet the increasing demand of the customers and to secure leading position among the competition, the company said in a statement.
© WOC News